The term triple-negative refers to the fact that breast cancer cells lose the expression of three major classes of hormone receptors: estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2). This evidence concerns the gene ERBB2 and breast cancer.